Insulet corporation stock

Insulet Corporation stock has a Value Score of 2, Growth

The consensus among analysts is that Insulet Corporation (PODD) is an Overweight stock at the moment, with a recommendation rating of 1.62. 0 analysts rate the stock as a Sell, while 3 rate it as Overweight. 6 out of 24 have rated it as a Hold, with 15 advising it as a Buy. 0 have rated the stock as Underweight.Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced a series of initiatives in recognition of National Diabetes Awareness Month and World Diabetes Day. “Our commitment to people with diabetes extends beyond our …Oct 4, 2023 · PODD stock, the ticker symbol for Insulet Corp, has been performing well in recent months and is expected to continue its upward trajectory. According to data from CNN Money, the 18 analysts offering 12-month price forecasts for Insulet Corp have a median target of $280.00, with a high estimate of $360.00 and a low estimate of $185.00.

Did you know?

The stock carries a Zacks Rank #3 (Hold). Insulet has been progressing well with respect to its four-pillar strategy, where the first two pillars include expanding access and awareness and ...So, based on the above formula, the ROE for Insulet is: 20% = US$120m ÷ US$608m (Based on the trailing twelve months to September 2023). The 'return' refers to a company's earnings over the last year. Another way to think of that is that for every $1 worth of equity, the company was able to earn $0.20 in profit.So, based on the above formula, the ROE for Insulet is: 20% = US$120m ÷ US$608m (Based on the trailing twelve months to September 2023). The 'return' refers to a company's earnings over the last year. Another way to think of that is that for every $1 worth of equity, the company was able to earn $0.20 in profit.Insulet Corporation Common Stock (PODD) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.On July 21, 2023, Insulet Corporation (NASDAQ:PODD) stock closed at $284.28 per share. One-month return of Insulet Corporation (NASDAQ:PODD) was -4.20%, and its shares gained 18.16% of their value ...Insulet Corporation , headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and ...ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced plans to release its financial results for the fourth quarter and full year of 2022 on February 23, 2023 after the close of the financial markets.Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $11.14B. -30.1%. Market Cap / Employee. The market cap of a ...Discover historical prices for PODD stock on Yahoo Finance. View daily, weekly or monthly format back to when Insulet Corporation stock was issued.ACTON, Mass.-- (BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that management will present at two upcoming investor conferences (all Eastern Time): The Nasdaq 29 th Investor Conference in London on Tuesday, December 5 ...Insulet Corporation specializes in the design, manufacture and marketing of medical devices intended to improve the lives of people with insulin-dependent diabetes. In addition, the group offers non-insulin subcutaneous drug delivery systems used in several therapeutic areas.WMT -0.72%. Get Free Report. . In addition to the effects of weight loss drug popularity on Insulet shares, the stock was trading lower on Wednesday after the company announced on Tuesday that ...At Insulet Corporation, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.Insulet Corporation specializes in the design, manufacture and marketing of medical devices intended to improve the lives of people with insulin-dependent diabetes. …UKRAINE - 2021/06/11: In this photo illustration an Insulet Corporation logo is seen on a smartphone ... Insulet stock (NASDAQ NDAQ: PODD) currently trades at $156 per share, about 29% lower than ...Insulet Corp Shs Aktie Profil. Die Insulet Corp Shs Aktie wirACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NA Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $11.14B. -30.1%. Market Cap / Employee. The market cap of a ... Jun 20, 2023 · ACTON, Mass.--(BUSINESS WIRE)-- Ins However, Insulet's stock has dropped by 60% since its recent highs in May, thanks to the belief that drugs like Ozempic and Wegovy will greatly hurt demand. Is the Insulet Corporation selloff ...Insulet Corporation Stock Price History. Insulet Corporation’s price is currently down 30.73% so far this month. During the month of August, Insulet Corporation’s stock price has reached a high of $277.65 and a low of $178.55. Over the last year, Insulet Corporation has hit prices as high as $335.91 and as low as $178.55. Insulet Corp. is a medical device company, which engages in t

The stock carries a Zacks Rank #3 (Hold). Insulet has been progressing well with respect to its four-pillar strategy, where the first two pillars include expanding access and awareness and ...Insulet Corporation (PODD) Q3 2021 Earnings Call Transcript PODD earnings call for the period ending September 30, 2021. Motley Fool Transcribers | Nov 4, 2021 View the latest Insulet Corp. (PODD) stock price, news, historical charts, analyst ratings and financial information from WSJ.Oct 5, 2023 · WMT -0.72%. Get Free Report. . In addition to the effects of weight loss drug popularity on Insulet shares, the stock was trading lower on Wednesday after the company announced on Tuesday that ... Get the latest Insulet Corporation (GOV) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Indian Oil Corporation Ltd., Tata Motors Ltd., Reliance Industries Ltd. and the State Bank of India are four of the biggest joint stock companies of India. A joint stock company is simply a business entity in which stakes are owned jointly ...Insulet Corporation specializes in the design, manufacture and marketing of medical devices intended to improve the lives of people with insulin-dependent diabetes. …Insulet Corporation specializes in the design, manufacture and marketing of medical devices intended to improve the lives of people with insulin-dependent diabetes. ... Stock Insulet Corporation - Nasdaq . News Insulet Corporation. Transcript : Insulet Corporation Presents at Wells Fargo Securities Healthcare Conference 2023, Sep-07 ……

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Competitors. PODD | Complete Insulet Corp. stock news by MarketWatch. . Possible cause: Insulet Corporation : News, information and stories for Insulet Corporation | Nasdaq: PO.

Insulet Corporation (PODD) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Add to watchlist. 158.27 -4.31 (-2.65%) As of 01:16PM EST. Market open. 1d. 5d.Insulet Corporation is an innovative medical device company based in Acton, Massachusetts. It was founded in 2000 with the mission of improving the lives of people with diabetes. Specifically, through our revolutionary Omnipod Insulin Management System, we seek to expand the use of insulin pump therapy. Learn More.Get real-time stock quotes, market cap, and other data for Insulet Corporation Common Stock (PODD), a medical device company that develops and manufactures insulin pumps and sensors. See the bid and ask prices, after-hours trading, and historical performance of PODD on Nasdaq.

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Insulet Corporation shares valued at $3,286,600 were sold by Petrovic Shacey on Nov 13. At $164.33 per share, Petrovic Shacey sold 20,000 shares.Sep 12, 2023 · The stock carries a Zacks Rank #3 (Hold). Insulet has been progressing well with respect to its four-pillar strategy, where the first two pillars include expanding access and awareness and ... Insulet Corporation (PODD) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 181.32 +0.06 (+0.03%) At close: 04:00PM EST 180.64 -0.68 …

Insulet Corp Shs Aktie Profil. Die Insulet Corp Shs Aktie wird At Insulet Corporation, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced the FDA clearance of its latest innovation, Omnipod GO™, an insulin delivery device cleared for use for people with type 2 diabetes age 18 or older who would typically take daily injections of ... Insulet Corporation (PODD) NasdaqGS - NasdaqGS Real Time PACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation ACTON, Mass.-- (BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that management will present at two upcoming investor conferences (all Eastern Time): The Nasdaq 29 th Investor Conference in London on Tuesday, December 5 ... Insulet Corp. is a medical device company, which enga What happened. Shares of Insulet (PODD 0.88%) were up 15.3% this week as of the market close on Thursday, according to data from S&P Global Market Intelligence.The big jump came following a report ...Get real-time stock quotes, market cap, and other data for Insulet Corporation Common Stock (PODD), a medical device company that develops and manufactures insulin … Insulet – Nasdaq Stock Market Closing Bell Ceremony. November 14, 2Insulet Corporation quote is equal to 187.950 USD at 2023-11-27.ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) Insulet Corporation’s Stock Price as of Market Close. As of November 13, 2023, 4:00 PM, CST, Insulet Corporation’s stock price was $163.71. Insulet Corporation is up 5.55% from its previous closing price of $155.10. During the last market session, Insulet Corporation’s stock traded between $152.04 and $157.64. Currently, there are …Company profile page for Insulet Corp including stock price, company news, press releases, executives, board members, and contact information Insulet Corporation Stock Price History. Insulet Corporation’s pri On Monday, Insulet Corporation [NASDAQ:PODD] saw its stock jump 4.14% to $181.26. On the same session, the stock had its day’s lowest price of $172.61, but rose to a high of $181.65. Over the last five days, the stock has gained 10.72%. Insulet Corporation shares have fallen nearly -38.43% since the year began.Insulet Corporation (PODD) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. Visitors trend 2W 10W 9M. 172.95 +9.24 (+5.64%) At close: 04:00PM EST. ... Stock. Insulet (PODD) shares ... Stock analysis for Insulet Corp (PODD:NASDAQ GS) including stock [Insulet Corporation (NASDAQ: PODD) (Insulet1 Mei 2020 ... Our CEO, Shacey Petrovic, shares how we ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced financial results for the three months ended June 30, 2023.Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.